BPH GLOBAL LTD
ASX:BP8Pharmaceuticals, Biotechnology & Life SciencesToday’s holders own 95.8% of what they think they own, once every option and right converts.
Runway under 2 quarters; share count grew 493% in 24 months; 8 cash raises in 24 months
BPH GLOBAL LTD has a stated share consolidation planned for September 2026, at approximately a 1-for-10 ratio. The latest reported share count, adjusted for consolidation, stands at 2.35B shares as of February 2026. Growth in the share count over the last 24 months is not stated, as the ASX market reading ends earlier than the disclosed filing date. In the past 24 months, the company completed 8 capital raises totalling A$3.4M, with the most recent being a A$1.0M placement in February 2026. Options and rights on issue could convert into 104M new shares, representing 4.4% of the current share count, with none in the money; the nearest expiry is December 2026. As of the June 2026 quarter, the company reported negative A$127K in available cash, indicating a shortfall of 0.3 quarters of funding. No proposed securities issues are currently pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 16 Apr 2026 | 3H · cancellation | BP8 : ORDINARY FULLY PAID | 2.35B | Appendix 3H |
| 13 Feb 2026 | 2A · quoted issue | BP8 : ORDINARY FULLY PAID | 2.35B | Appendix 2A |
| 24 Dec 2025 | 3H · cancellation | BP8 : ORDINARY FULLY PAID | 1.85B | Appendix 3H |
| 16 Dec 2025 | 3G · unquoted | ORDINARY FULLY PAID | 1.85B | Appendix 3G |
| 11 Dec 2025 | 3G · unquoted | BP8 : ORDINARY FULLY PAID | 1.85B | Appendix 3G |
Capital raises
8 cash raises in the last 24 months · 2 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
consolidation-adjusted Figures rebased for the share consolidation on record.
- Price-triggered92.1M · 3.9% of sharesOptions and warrants — they convert when the share price clears their exercise price.At least 16.7M of it states no exercise price — that much cannot be called in or out of the money.
- Condition-triggered12.0M · 0.5% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 75.4M priced, 28.7M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
At $0.0010 today, 0 securities are in the money (0.0% of shares on issue). No price up to ten times today’s switches on any more priced supply.
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 28.7M (27.6% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
- 75.4M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| BP8AD | Options | Price-triggered | $0.20 | 11 Dec 2026 | 13.8M | Filing |
| BP8AO | Options | Price-triggered | $0.50 | 28 Feb 2027 | 10k | Filing |
| BP8AM | Options | Price-triggered | $0.85 | 28 Feb 2027 | 100k | Filing |
| BP8AN | Options | Price-triggered | $1.00 | 28 Feb 2027 | 100k | Filing |
| BP8O | Options | Price-triggered | — | 7 July 2027 | 4.4M | Filing |
| BP8AJ | Options | Price-triggered | $2.50 | 1 Nov 2027 | 500k | Filing |
| BP8AE | Options | Price-triggered | $0.060 | 2 Dec 2027 | 13.6M | Filing |
| BP8AF | Options | Price-triggered | $0.040 | 4 Dec 2027 | 38.9M | Filing |
| BP8AC | Options | Price-triggered | $0.060 | 13 Dec 2027 | 1.8M | Filing |
| BP8AV | Options | Price-triggered | $0.060 | 28 Feb 2028 | 6.7M | Filing |
| BP8AG | Performance rights | Condition-triggered | — | — | 12.0M | Filing Meeting |
| BP8AA | Options | Price-triggered | — | — | 12.3M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 27 Nov 2025 | Francesco Cannavo | Other incentive | 105.5M | 833k | 30.0M | — | 3Y notice |
| 27 Nov 2025 | Matthew Leonard | Other incentive | 121.2M | 833k | 30.0M | — | 3Y notice |
| 27 Nov 2025 | Paul Stephenson | Other incentive | 107.2M | 833k | 30.0M | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.